Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models

Oncology Letters

Volumn 4, Issue 5, 2012, Pages 976-980

  Zhou, Juying ^a   Wang, Lili ^a   Xu, Xiaoting ^a   Tu, Yu ^b   Qin, Songbing ^a   Yin, Yuzhen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Antitumor activity; Combination therapy; Endostar; Nasopharyngeal carcinoma; Radiation

Indexed keywords

RECOMBINANT ENDOSTATIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER TISSUE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; MONOTHERAPY; MOUSE; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; RADIOSENSITIZATION; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 84866071756     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.856     Document Type: Article

References (20)

1. Yin WB and Gu XZ (eds): Nasopharyngeal carcinoma. In: Radiation Oncology. 4th edition. Peking Union Medical College Press, Beijing, p480, 2007.
2. Kwong D, Sham J and Choy D: The effect of loco-regional control on distant metastastic dissemination in nasopharyngeal carcinoma: an analysis of 1301 patients. Int J Radiat Oncol Biol Phys 30: 1029-1036, 1994.
3. Langeland Marthinsen AB, Dybdahl Wanderas A, LundgrenS, Strickert T, et al: Effects of growth factors on growth and radiation sensitivity of the human breast cancer cell line T-47D. Oncol Rep 9: 397-403, 2002.
4. Hovinga KE, Stalpers LJ, Van Bree C, et al: Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines-a clue to radioresistance. J Neurooncol 74: 99-103, 2005.
5. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18, 2002.
6. Feldman AL, Restifo NP, Alexander HR, et al: Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. Cancer Res 60: 1503-1506, 2000.
7. Ling Y, Yang Y, Lu N, et al: Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells. Biochem Biophys Res Commun 361: 79-84, 2007.
8. Mäkitie T, Summanen P, Tarkkanen A, et al: Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 40: 2471-2480, 1999.
9. Tokuraku M, Sato H, Murakami S, et al: Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 64: 355-359, 1995.
10. Gerger A, El-Khoueiry A, Zhang W, et al: Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res 17: 5783-5792, 2011.
11. Ma J, Chen CS, Blute T and Waxman DJ: Antiangiogenesis enhances intratumoral drug retention. Cancer Res 71: 2675-2685, 2011.
12. Wang ZX, Wang SM, Zhou Q, et al: Endostatin in different administration routes combined with adriamycin chemotherapy in the treatment of liver cancer xenograft in mice. Nan Fang Yi Ke Da Xue Xue Bao 30: 1903-1905, 2010 (In Chinese).
13. Teicher BA, Dupuis N, Kusomoto T, et al: Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy. Rad Oncol Invest 2: 269-276, 1994.
14. Hansen-Algenstaedt N, Stoll BR, Padera TP, et al: Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy. Cancer Res 60: 4556-4560, 2000.
15. Luo X, Slater JM and Gridley DS: Radiation and endostatin gene therapy in a lung carcinoma model: pilot data on cells and cytokines that affect angiogenesis and immune status. Techol Cancer Res Treat 5: 135-146, 2006.
16. Itasaka S, Komaki R, Herbst RS, et al: Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenograft in mice. Int J Radiat Oncol Biol Phys 67: 870-878, 2007.
17. Lee CG, Heijn M, di Tomaso E, et al: Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic condition. Cancer Res 60: 5565-5570, 2000.
18. Abdollahi A, Lipson KE, Han X, et al: SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct antiendothelial action of radiation in vitro. Cancer Res 63: 3755-3763, 2003.
19. Kaliski A, Lassau L, Maggiorella L, et al: Antiangiogenic effect and tumor growth control achieved by an MMP-inhibitor combined to radiation in vivo, targeting radio-induced MMP-2 enhancement and VEGF modulation. Int J Radiat Oncol Biol Phys 60: 368-369, 2004.
20. Topolovec Z, Corusić A, Babić D, et al: Vascular endothelial growth factor and intratumoral microvessel density as prognostic factors in endometrial cancer. Coll Antropol 34: 447-453, 2010.